INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. Innovita Biological Technology Co., Ltd. Stock
Equities
688253
CNE100005Q14
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.1 CNY | -5.96% |
|
+15.88% | +68.33% |
| 04-15 | Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-12 | China stocks track Asian markets lower on rate concerns | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 447M 61.81M 84.53M | Sales 2023 | 478M 66.16M 90.48M | Capitalization | 3.4B 471M 644M |
|---|---|---|---|---|---|
| Net income 2022 | 151M 20.9M 28.58M | Net income 2023 | 174M 24.08M 32.93M | EV / Sales 2022 | 3.94 x |
| Net cash position 2022 | 1.48B 205M 280M | Net cash position 2023 | 1.69B 234M 321M | EV / Sales 2023 | 3.57 x |
| P/E ratio 2022 |
19.2
x | P/E ratio 2023 |
19.5
x | Employees | 404 |
| Yield 2022 |
0.7% | Yield 2023 |
1.6% | Free-Float | 36.84% |
More Fundamentals
* Assessed data
More news
| 1 day | -5.96% | ||
| 1 week | +15.88% | ||
| Current month | +15.88% | ||
| 1 month | +17.83% | ||
| 3 months | +37.22% | ||
| 6 months | +75.05% | ||
| Current year | +68.33% |
1 week
36.71
47.85
1 month
29.3447.85
Current year
23.6147.85
1 year
19.1247.85
3 years
19.1247.85
5 years
19.1247.85
10 years
19.1247.85
| Managers | Title | Age | Since |
|---|---|---|---|
Xiu Jie Zhang
FOU | Founder | 53 | 06-02-05 |
Xiu Juan Zhao
DFI | Director of Finance/CFO | 50 | 16-09-30 |
Song Ling Li
CHM | Chairman | 43 | 13-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tian Long Hu
BRD | Director/Board Member | 47 | 20-11-08 |
Jian Sun
BRD | Director/Board Member | 42 | 20-11-08 |
Yi Lin
BRD | Director/Board Member | 55 | 19-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 42.1 | -5.96% | 4 975 238 |
| 24-05-09 | 44.77 | +0.47% | 4,410,939 |
| 24-05-08 | 44.56 | -4.50% | 6,155,086 |
| 24-05-07 | 46.66 | +7.02% | 8,738,694 |
| 24-05-06 | 43.6 | +20.01% | 7,913,094 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotes
Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of point-of-care testing (POCT) rapid diagnostic products. The Company's main products include novel coronavirus (2019-nCoV) neutralizing antibody detection kits using colloidal gold, quantum dot fluorescence immunochromatography and chemiluminescence techniques, and respiratory pathogen detection products, such as whole blood respiratory quintuple detection card, influenza virus triple detection card, virus serum quintuple detection card, respiratory pathogen nine indirect immunofluorescence kit, and others.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +68.33% | 844M | |
| -1.29% | 12.64B | |
| -0.47% | 8.37B | |
| +5.68% | 5.37B | |
| +22.61% | 5.26B | |
| -2.03% | 4.58B | |
| -53.56% | 3.16B | |
| +19.30% | 2.89B | |
| -8.42% | 2.22B | |
| -3.55% | 1.91B |
- Stock Market
- Equities
- 688253 Stock
